Skip to main content

Table 2 Pharmacist responses against the suspected COVID-19 case

From: Provision of pharmaceutical care to suspected high-risk COVID-19 patients through telehealth: a nationwide simulated patient study

Responses

n (or %)*

Pharmacists’ responses related to possible COVID-19 infection

 Assured the SP that her symptoms are related to the common flu

2

 Informed the SP that she might have been infected with COVID-19

38

 Confirmed that the symptoms are related to COVID-19

5

 Recommended an antipyretic for fever

27

 Recommended other medication(s)

7

 Recommended a supplement

16

 Recommended non-pharmacological measure(s)

2

 Advised the SP to adhere to PPE (e.g., facial mask, hand disinfectant, and gloves)

6

 Advised the SP to monitor red flag symptoms

11

 Advised the SP to isolate herself for 14 days

4

 Advised the SP to avoid contacting others (especially her mother)

15

 Advised the SP to seek medical attention because she was a high-risk patient

39

 Advised the SP to test for PCR

41

 Advised the SP to consult a health care provider if the PCR test was positive

3

 Advised the SP to contact the Ministry of Public Health

2

Recommendations related to DM

 Advised the SP to keep monitoring her blood glucose levels

16

 Advised the SP to avoid sugar intake

11

 Advised the SP to increase her insulin dose

2

 Advised the SP to check the HbA1C level

2

No recommendations were given

 The pharmacists stated that he/she was busy and requested ending the call

14

 The pharmacists did not give any recommendation and advised the SP to seek medical attention

20

 Advised the SP to consult a physician because pharmacists are not qualified to handle such a case

1

  1. DM diabetes mellitus, Hb hemoglobin, PCR polymerase chain reaction, PPE personal protective equipment, SP simulated patient
  2. *Since the number of pharmacists is 100, the result indicates the percentage too. As mixed responses were given, numbers do add up to 100